These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28459733)

  • 21. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.
    Agersø H; Jensen LB; Elbrønd B; Rolan P; Zdravkovic M
    Diabetologia; 2002 Feb; 45(2):195-202. PubMed ID: 11935150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of low dose dexmedetomidine premedication on propofol consumption in geriatric end stage renal disease patients.
    Ergenoglu P; Akin S; Bali C; Eker HE; Yalcin Cok O; Aribogan A
    Braz J Anesthesiol; 2015; 65(5):326-32. PubMed ID: 26323728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.
    Pejo E; Ge R; Banacos N; Cotten JF; Husain SS; Raines DE
    Anesthesiology; 2012 May; 116(5):1057-65. PubMed ID: 22417966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults.
    Shrewsbury SB; Hocevar-Trnka J; Satterly KH; Craig KL; Lickliter JD; Hoekman J
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32609960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers.
    Kaneda K; Yamashita S; Woo S; Han TH
    J Clin Pharmacol; 2011 Apr; 51(4):482-91. PubMed ID: 20498288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of alpha(2)-antiplasmin by microplasmin: a randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers.
    Pakola S; Cahillane G; Stassen JM; Lijnen HR; Verhamme P
    Clin Ther; 2009 Aug; 31(8):1688-706. PubMed ID: 19808128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics.
    Valk BI; Struys MMRF
    Clin Pharmacokinet; 2021 Oct; 60(10):1253-1269. PubMed ID: 34060021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT017, an Antiplatelet GPVI (Glycoprotein VI) Fab.
    Voors-Pette C; Lebozec K; Dogterom P; Jullien L; Billiald P; Ferlan P; Renaud L; Favre-Bulle O; Avenard G; Machacek M; Plétan Y; Jandrot-Perrus M
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):956-964. PubMed ID: 31017822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.
    Lasseter KC; Shaughnessy L; Cummings D; Pezzullo JC; Wargin W; Gagnon R; Oliva J; Kosutic G
    J Clin Pharmacol; 2008 Feb; 48(2):193-202. PubMed ID: 18199894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.
    Peters E; Heuberger JAAC; Tiessen R; van Elsas A; Masereeuw R; Arend J; Stevens J; Pickkers P
    Clin Pharmacokinet; 2016 Oct; 55(10):1227-1237. PubMed ID: 27147514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.
    Schulte HM; Benker G; Reinwein D; Sippell WG; Allolio B
    J Clin Endocrinol Metab; 1990 May; 70(5):1426-30. PubMed ID: 2159485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example.
    Schüttler J; Schwilden H; Stoeckel H
    Eur J Anaesthesiol; 1985 Jun; 2(2):133-42. PubMed ID: 4029127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects.
    Nunes T; Machado R; Rocha JF; Fernandes-Lopes C; Costa R; Torrão L; Loureiro AI; Falcão A; Vaz-da-Silva M; Wright L; Almeida L; Soares-da-Silva P
    Clin Ther; 2009 Oct; 31(10):2258-71. PubMed ID: 19922897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
    Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
    Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
    Becker NP; Haberland A; Wenzel K; Göttel P; Wallukat G; Davideit H; Schulze-Rothe S; Hönicke AS; Schimke I; Bartel S; Grossmann M; Sinn A; Iavarone L; Boergermann JH; Prilliman K; Golor G; Müller J; Becker S
    Clin Drug Investig; 2020 May; 40(5):433-447. PubMed ID: 32222912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of FospropofolFD Compared to Propofol When Given During the Induction of General Anaesthesia: A Phase II, Multi-centre, Randomized, Parallel-Group, Active-Controlled, Double-Blind, Double-Dummy Study.
    Liu R; Luo C; Liu J; Zhang W; Li Y; Xu J
    Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):93-100. PubMed ID: 26781338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.